Weak Magnetic Fields in the Treatment of Parkinson's Disease with the “on-off” Phenomenon

References

• Andersen K., Balldin J., Gottfries C. G., Granerus A. K., Modigh K., Svennerholm L., Wallin A. A double‐blind evaluation of electroconvulsive therapy in Parkinson's disease with “on‐off” phenomena. Acta Neurologica Scandinavica 1987; 76: 191–199
   PubMed Web of Science ®Google Scholar
• Anninos P. A., Tsagas N., Sandyk R., Derpapas K. Magnetic stimulation in the treatment of partial seizures. International Journal of Neuroscience 1991; 60: 141–171
   PubMed Web of Science ®Google Scholar
• Anton‐Tay F., Diaz J. L., Fernandez‐Guardiola A. On the effects of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Balldin J., Eden S., Granerus A. K., Modigh K., Svanborg A., Walinder J., Wallin L. Eectroconvulsive therapy in Parkinson's syndrome with “on‐off” phenomenon. Journal of Neural Transmission 1980; 47: 11–21
   PubMedGoogle Scholar
• Barbeau A. L‐dopa therapy in Parkinson's disease: A critical review of 9 years' experience. Canadian Medical Association Journal 1969; 101: 59–68
   PubMed Web of Science ®Google Scholar
• Blask D. E., Nodelman J. L., Leadem C. A. Preliminary evidence that a dopamine receptor antagonist blocks the prolactin‐inhibitory effects of melatonin in anosmic male rats. Experientia 1980; 36: 1008–1009
   PubMedGoogle Scholar
• Bradbury A. J., Kelly M. F., Smith J. A. Melatonin action in the mid‐brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Burton J. L., Cartlidge M., Shuster S. Effect of L‐dopa on the seborrhea of Parkinsonism. British Journal of Dermatology 1973a; 88: 475–479
   PubMed Web of Science ®Google Scholar
• Burton J. L., Cartlidge M., Cartlidge N. E. F., Shuster S. Sebum secretion in Parkinsonism. British Journal of Dermatology 1973b; 88: 263–266
   PubMed Web of Science ®Google Scholar
• Cardinali D. P., Yacas M. I., Boyer E. E. Specific binding of melatonin in bovine brain. Endocrinology 1979; 105: 437–441
   PubMed Web of Science ®Google Scholar
• Carlson A. Biochemical implications of DOPA induced actions on the central nervous system with particular reference to abnormal movements. L‐Dopa and parkinsonism, A. Barbeau, F. H. McDowell. F. A. Davis, Philadelphia 1970; 205–213
   Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movement induced by L‐dopa in mice. Science 1971; 173: 450–452
   PubMed Web of Science ®Google Scholar
• Cremer‐Bartels G., Krause K., Kuchle H. J. Influence of low magnetic‐field‐strength variations on the retina and pineal gland of quail and humans. Graefe's Archives of Clinical and Experimental Ophthalmology 1983; 220: 248–252
   PubMed Web of Science ®Google Scholar
• Dubocovich M. L. Melatonin is a potent modulator of dopamine release in the retina. Nature 1983; 306: 782–784
   PubMed Web of Science ®Google Scholar
• Duvoisin R., Yahr M. D. Behavioural abnormalities occurring in parkinsonism during treatment with L‐dopa. L‐dopa and behaviour, S. Malitz. Raven Press, New York 1970
   Google Scholar
• Fahn S. Fluctuations of disability in Parkinson's disease: pathophysiology. Movement disorders, C. D. Marsden, S. Fahn. Butterworths, London 1982; 119–126
   Google Scholar
• Gaffori O., Van Ree J. M. Serotonin and antidepressant drugs antagonize melatonin‐induced behavioural changes after injection into the nucleus accumbens of rats. Neuropharmacology 1985; 24: 237–244
   PubMed Web of Science ®Google Scholar
• Golus P., King M. The effects of melatonin in open field behavior. Pharmacology, Biochemistry and Behavior 1981; 15: 883–885
   PubMed Web of Science ®Google Scholar
• Hardie R. J. Levodopa related motor fluctuations. Parkinson disease, G. Stern. Chapman and Hall Medical, London 1990; 559–596
   Google Scholar
• Hardie R. J., Lees A. J., Stern G. M. On‐off fluctuations in Parkinsons disease, a clinical and neuropharmacological study. Brain 1984; 107: 487–506
   PubMed Web of Science ®Google Scholar
• Hyyppa M., Rinne U. K., Sonninen V. The activating effect of L‐dopa treatment on sexual function and its experimental background. Acta Neurologica Scandinavica 1970; 43: 223–224, (suppl)
   Google Scholar
• Kales A., Ansel R. D., Markham C. H., Scharf M. B., Tan T. L. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clinical Pharmacology and Therapeutics 1971; 4: 397–406
   Google Scholar
• Karson C. N., Staub R. A., Kleinman J. E., Wyatt R. J. Drug effect on blink rates in rhesus monkeys: preliminary studies. Biological Psychiatry 1981a; 16: 249–254
   PubMed Web of Science ®Google Scholar
• Karson C. N., Freed W. J., Kleinman J. E., Bigelow L. B., Wyatt R. J. Neuroleptics decrease blinking in schizophrenic subjects. Biological Psychiatry 1981b; 16: 679–682
   PubMed Web of Science ®Google Scholar
• Kendel K., Beck U., Wita C., Hohneck E., Zimmermann H. Der Einfluss von L‐dopa auf den Nachtschlaf bein Patienten mit Parkinson‐Syndrom. Archives fur Psychiatrie und Nervenkrakheiten 1972; 216: 82–100
   PubMedGoogle Scholar
• Klawans H. L., Weiner W. J. Textbook of clinical neuropharmacology. Raven Press, New York 1981
   Google Scholar
• Klawans H. L., Ilahi M. M., Shenker D. Theoretical implications of the use of L‐Dopa in parkinsonism. Acta Neurologica Scandinavica 1970; 46: 409–441
   PubMed Web of Science ®Google Scholar
• Klawans H. L., Hitri A., Barr A. Levodopa‐induced dyskinesias. Parkinson's disease, G. Stem. Chapman and Hall Medical, London 1990; 537–557
   Google Scholar
• Koller W. C., Hubble J. P. Levodopa therapy in Parkinson's disease. Neurology 1990; 40(supp 3)40–47
   Google Scholar
• Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Kovacs G. L., Gayari I., Telegdy G., Lissak K. Effect of melatonin and pinealectomy on avoidance and exploratory activity in the rat. Physiology, & Behavior 1974; 13: 349–355
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• LeWitt P. A., Chase T. N. “On‐Off” effects: the new challenge in parkinsonism. Trends in Neuroscience 1983; 6: 1–4
   Web of Science ®Google Scholar
• Marsden C. D. Parkinson's disease. Lancet 1990; 335: 948–952
   PubMed Web of Science ®Google Scholar
• Marsden C. D., Parkes J. D. “On and off” variability and response swings in Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1981; 265–274
   Google Scholar
• Nausieda P. A. Sleep disorders. Handbook of parkinson's disease, W. C. Koller. Marcel Dekker, New York 1987; 371–380
   Google Scholar
• Nauta H. J. W. The relationship of the basal ganglia to the limbic system. Handbook, of clinical neurology: extrapyramidal disorders, P. J. Vinken, G. W. Bruyn, H. L. Klawans. Elsevier Science Publishers, North Holland 1986; vol. 5: 19–31
   Google Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. European Journal of Pharmacology 1979; 55: 219–220
   PubMed Web of Science ®Google Scholar
• Nowak J. Z. Melatonin inhibits (3H) dopamine release from rabbit retina evoked by light, potassium, and electrical stimulation. Medical Science Research 1988; 16: 1073–1075
   Google Scholar
• Null J. C., Woodward W. R., Hammerstad J. P., Carter J. H., Anderson J. L. The “on‐off” phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. New England Journal of Medicine 1984; 310: 483–488
   PubMed Web of Science ®Google Scholar
• Obeso J. A., Grandas F., Vaemonde J. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology 1989; 11(suppl 2)11–18
   Google Scholar
• Olcese J., Reuss S. Magnetic field effects on pineal gland melatonin synthesis: comparative studies on albino and pigmented rodents. Brain Research 1986; 369: 365–368
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S., Vollrath L. Evidence for the involvement of the visual system in mediating magnetic field effects on pineal melatonin synthesis in the rat. Brain Research 1985; 333: 382–384
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S., Semm P. Geomagnetic field detection in rodents. Life Sciences 1988; 42: 605–613
   PubMed Web of Science ®Google Scholar
• Pederzoli M., Girotti F., Scigliano G., Aiello G., Carella F., Caraceni T. L‐dopa long term treatment in Parkinson's disease: age‐related effects. Neurology 1983; 33: 1518–1522
   PubMed Web of Science ®Google Scholar
• Quinn N. P. Levodopa. Handbook of parkinson's disease, W. C. Koller. Marcel Dekker, New York 1987; 317–337
   Google Scholar
• Quinn N. P., Toone B., Lang A. E., Marsden C. D., Parkes J. D. Dopa dose‐dependent sexual deviation. British Journal of Psychiatry 1983; 142: 296–298
   PubMed Web of Science ®Google Scholar
• Rudolph K., Krauchi K., Wirz‐Justice A., Peer H. Weak 50‐Hz electromagnetic fields activate rat open field behavior. Physiology, & Behavior 1985; 35: 505–508
   PubMed Web of Science ®Google Scholar
• Rudolph K., Wirz‐Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Sandier M. Some anomalies in the L‐dopa response: recent biochemical studies. Archives of Neurology 1970; 5: 259–263
   Google Scholar
• Sandyk R. Relevance of the habenular complex to neuropsychiatry. A review and hypothesis. International Journal of Neurosciencc 1991; 61: 189–219
   PubMed Web of Science ®Google Scholar
• Sandyk R., Anninos P. A., Tsagas N. Magnetic fields and the habenular complex. International Journal of Neuroscience 1991; 59: 263–266
   PubMed Web of Science ®Google Scholar
• Sandyk R., Anninos P. A., Tsagas N., Derpapas K. Magnetic fields in the treatment of Parkinson's disease. International Journal of Neuroscience 1992; 63: 141–150
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased incidence of neuroleptic‐induced movement disorders in pinealectomized rats. International Journal of Neuroscience 1989; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Segucla P., Geffard M., Chauveau J., Muyard J. P., Biziere K., Le Moal M. Selective increase of melatonin content in pineal gland and nucleus accumbens after peripheral injection of Des‐Try1‐gamma‐endorphin in the rat. Neuroscience Letters 1982; 10: S442
   Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P., Schneider T., Vollrath L. Effects of an earth‐strength magnetic field on electrical activity of pineal cells. Nature 1980; 288: 607–608
   PubMed Web of Science ®Google Scholar
• Stevens J. R. Eye blink and schizophrenia: psychosis, or ytardive dyskinesia. American Journal of Psychiatry 1978; 135: 223–227
   PubMed Web of Science ®Google Scholar
• Sugden J. Psychopharmacological effects of melatonin in mouse and rat. Journal of Pharmacology and Experimental Therapeutics 1983; 227: 587–591
   PubMed Web of Science ®Google Scholar
• Vitte P. A., Harthe C., Lestage P., Claustrat B., Bobillier P. Plasma. CSF and brain distribution of C14‐melatonin in rat: a biochemical and autoradiographic study. Journal of Pineal Research 1988; 5: 437–453
   PubMed Web of Science ®Google Scholar
• Wartenberg R. Neurologische Uniersuchungsmethoden in der Sprechstunde. Thieme Verlag, Stuttigart 1958
   Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N‐acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus. Brain Research 1983; 272: 378–381
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Brain Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Bgozi Y., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle. Neuroendocrinology 1983; 37: 41–47
   PubMed Web of Science ®Google Scholar